Pharma
Global Actinic Keratosis Treatment Market Opportunities and Forecast 2020-2027
  • DLR2102
  • 26 February, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Actinic Keratosis Treatment Market, By Therapy (Topical Medications, Procedures, Photodynamic Therapy) By End User (Hospitals and Oncology Centers, Dermatology Clinics, Other) and opportunities and forecast 2020-2027

Actinic Keratosis Treatment Market Overview

Precancerous skin lesions known as actinic keratosis (AK) or solar keratoses develop on the epidermis as a result of long-term sun exposure. These lesions have the potential to become cancerous in the future. As a result, treating such medical issues is an important aspect of skin cancer prevention. This sets the stage for the development of the global Actinic Keratosis Treatment market.
 
The rising prevalence of actinic keratosis, the increasing use of minimally invasive clinical therapies, the availability of adequate medical coverage, and the ageing population are all expected to drive demand. The upcoming arrival of pipeline drugs, as well as research and development of novel therapies with higher efficacy, convenient doses, and lower costs, all point to a promising future for the Actinic Keratosis Treatment market. The likelihood of metastases is greatly reduced when squamous cell carcinoma is treated early. This is a primary market driver for Actinic Keratosis Treatment. The demand for actinic keratosis treatments is increasing as people become more aware of the disease's negative consequences. Non-profit organizations and government agencies are also initiating public awareness campaigns to help the Actinic Keratosis Treatment market expand.
 
On the negative side, the high cost of actinic keratosis therapies, as well as the difficulties associated with the currently available care modules, are projected to restrict the growth of the actinic keratosis treatment market.
 
Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Therapy, End User, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Stanford Chemicals, Alma Lasers, 3M, Sun Pharmaceutical Industries Ltd., Gal derma S.A, Leo Pharma, Valeant Pharmaceuticals, BioLineRx, Cipher Pharmaceuticals Inc., Biofrontera AG.


Covid-19 Impact on Actinic Keratosis Treatment Market
 
In addition, the current Actinic Keratosis Treatment Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Actinic Keratosis Treatment Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Actinic Keratosis Treatment Market Segment Overview




Based on Therapy, Procedures accounted for the maximum share in the global Actinic Keratosis Treatment market and are expected to grow at the highest CAGR in the forecast period. Cryosurgery, chemical peels, Laser resurfacing, Photodynamic therapy, and the curettage process are some of the treatments used to treat actinic keratosis. Cryosurgery is a treatment that uses liquid nitrogen to remove damaged skin and allow new skin to grow in contaminated regions. In hospitals and clinics, it's a common process. Aside from that, a chemical peel is a thin coating of solution applied to lesions. It aids in the healing of superficial skin injury.
 
Actinic Keratosis Treatment Market, By Therapy
·       Topical Medications
·       Procedures
·       Photodynamic Therapy
 
Actinic Keratosis Treatment Market, By End User
·       Hospitals and Oncology Centers
·       Dermatology Clinics
·       Other

Actinic Keratosis Treatment Market Regional Overview

Based on the region, the global Actinic Keratosis Treatment market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share and is expected to grow at the highest CAGR in the forecast period. Moreover, Europe was the second-largest market in 2020. The increasing disease prevalence, rising consumer awareness, proactive government initiatives, technical developments, and improvements in healthcare infrastructure are all contributing to the growth of the North American Actinic Keratosis Treatment market during the forecast period.
 
Actinic Keratosis Treatment Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Actinic Keratosis Treatment Market, Key Players

·       Stanford Chemicals
·       Alma Lasers
·       3M
·       Sun Pharmaceutical Industries Ltd.
·       Gal derma S.A
·       Leo Pharma
·       Valeant Pharmaceuticals
·       BioLineRx
·       Cipher Pharmaceuticals Inc.
·       Biofrontera AG.

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the Actinic Keratosis Treatment market?

A. The upcoming arrival of pipeline drugs, as well as research and development of novel therapies with higher efficacy, convenient doses, and lower costs, all point to a promising future for the Actinic Keratosis Treatment market

Q2. Which Segments are covered in the Actinic Keratosis Treatment market report?

A. Therapy, End User, and Region. these segments are covered in the Actinic Keratosis Treatment market report

Q3. Which segment is projected to hold the largest share in the Actinic Keratosis Treatment market?

A. Procedures segment is projected to hold the largest share in the Actinic Keratosis Treatment market.

Q4. Which region holds the largest share in the Actinic Keratosis Treatment market?

A. North America held the largest share in the global Actinic Keratosis Treatment market

Q5. Which are the prominent players in the Actinic Keratosis Treatment market?

A. Stanford Chemicals, Alma Lasers, 3M, Sun Pharmaceutical Industries Ltd., Gal derma S.A, Leo Pharma, Valeant Pharmaceuticals, BioLineRx, Cipher Pharmaceuticals Inc., Biofrontera AG. are some key players in the Actinic Keratosis Treatment market
Actinic Keratosis Treatment Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Actinic Keratosis Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Therapy
        • 5.2.1. Topical Medications
        • 5.2.2. Procedures
        • 5.2.3. Photodynamic Therapy
      • 5.3. Market Analysis, Insights and Forecast – By End User
        • 5.3.1. Hospitals and Oncology Centers
        • 5.3.2. Dermatology Clinics
        • 5.3.3. Other
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Actinic Keratosis Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Therapy
        • 6.2.1. Topical Medications
        • 6.2.2. Procedures
        • 6.2.3. Photodynamic Therapy
      • 6.3. Market Analysis, Insights and Forecast – By End User
        • 6.3.1. Hospitals and Oncology Centers
        • 6.3.2. Dermatology Clinics
        • 6.3.3. Other
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Actinic Keratosis Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Therapy
        • 7.2.1. Topical Medications
        • 7.2.2. Procedures
        • 7.2.3. Photodynamic Therapy
      • 7.3. Market Analysis, Insights and Forecast – By End User
        • 7.3.1. Hospitals and Oncology Centers
        • 7.3.2. Dermatology Clinics
        • 7.3.3. Other
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Actinic Keratosis Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Therapy
        • 8.2.1. Topical Medications
        • 8.2.2. Procedures
        • 8.2.3. Photodynamic Therapy
      • 8.3. Market Analysis, Insights and Forecast – By End User
        • 8.3.1. Hospitals and Oncology Centers
        • 8.3.2. Dermatology Clinics
        • 8.3.3. Other
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Actinic Keratosis Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Therapy
        • 9.2.1. Topical Medications
        • 9.2.2. Procedures
        • 9.2.3. Photodynamic Therapy
      • 9.3. Market Analysis, Insights and Forecast – By End User
        • 9.3.1. Hospitals and Oncology Centers
        • 9.3.2. Dermatology Clinics
        • 9.3.3. Other
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Stanford Chemicals
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Alma Lasers
      • 10.6. 3M
      • 10.7. Sun Pharmaceutical Industries Ltd.
      • 10.8. Gal derma S.A
      • 10.9. Leo Pharma
      • 10.10. Valeant Pharmaceuticals
      • 10.11. BioLineRx
      • 10.12. Cipher Pharmaceuticals Inc.
      List of Figures

      Figure 1: Global Actinic Keratosis Treatment Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Actinic Keratosis Treatment Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Actinic Keratosis Treatment Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Actinic Keratosis Treatment Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Actinic Keratosis Treatment Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Actinic Keratosis Treatment Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Actinic Keratosis Treatment Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Actinic Keratosis Treatment Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934